title: PPARalpha ligands and clinical trials: cardiovascular risk reduction with fibrates.
authors.affiliation: Department of Medicine, Boston University School of Medicine, Massachusetts 02118, USA. sjrobins@bu.edu
authors.forename: S J
authors.initials: SJ
authors.lastname: Robins
mesh_terms: D002784:Cholesterol / Q000097:blood / Q000378:metabolism; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000517:prevention & control*; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008024:Ligands; D018160:Receptors, Cytoplasmic and Nuclear / Q000627:therapeutic use*; D012307:Risk Factors; D014157:Transcription Factors / Q000627:therapeutic use*
chemical_list: D000960:Hypolipidemic Agents; D008024:Ligands; D018160:Receptors, Cytoplasmic and Nuclear; D014157:Transcription Factors; D002784:Cholesterol